Literature DB >> 24583479

Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.

Michael Davenport1, Jordan Poles, Jacqueline M Leung, Martin J Wolff, Wasif M Abidi, Thomas Ullman, Lloyd Mayer, Ilseung Cho, P'ng Loke.   

Abstract

BACKGROUND: Inflammation during inflammatory bowel disease may alter nutrient availability to adherent mucosal bacteria and impact their metabolic function. Microbial metabolites may regulate intestinal CD4 T-cell homeostasis. We investigated the relationship between inflammation and microbial function by inferred metagenomics of the mucosal microbiota from colonic pinch biopsies of patients with inflammatory bowel disease.
METHODS: Paired pinch biopsy samples of known inflammation states were analyzed from ulcerative colitis (UC) (23), Crohn's disease (CD) (21), and control (24) subjects by 16S ribosomal sequencing, histopathologic assessment, and flow cytometry. PICRUSt was used to generate metagenomic data and derive relative Kyoto Encyclopedia of Genes and Genomes Pathway abundance information. Leukocytes were isolated from paired biopsy samples and analyzed by multicolor flow cytometry. Active inflammation was defined by neutrophil infiltration into the epithelium.
RESULTS: Carriage of metabolic pathways in the mucosal microbiota was relatively stable among patients with inflammatory bowel disease, despite large variations in individual bacterial community structures. However, microbial function was significantly altered in inflamed tissue of UC patients, with a reduction in carbohydrate and nucleotide metabolism in favor of increased lipid and amino acid metabolism. These differences were not observed in samples from CD patients. In CD, microbial lipid, carbohydrate, and amino acid metabolism tightly correlated with the frequency of CD4Foxp3 Tregs, whereas in UC, these pathways correlated with the frequency of CD4IL-22 (TH22) cells.
CONCLUSIONS: Metabolic pathways of the mucosal microbiota in CD do not vary as much as UC with inflammation state, indicating a more systemic perturbation of host-bacteria interactions in CD compared with more localized dysfunction in UC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24583479      PMCID: PMC4158619          DOI: 10.1097/MIB.0000000000000011

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  36 in total

1.  A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.

Authors:  Kathleen Machiels; Marie Joossens; João Sabino; Vicky De Preter; Ingrid Arijs; Venessa Eeckhaut; Vera Ballet; Karolien Claes; Filip Van Immerseel; Kristin Verbeke; Marc Ferrante; Jan Verhaegen; Paul Rutgeerts; Séverine Vermeire
Journal:  Gut       Date:  2013-09-10       Impact factor: 23.059

2.  Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach.

Authors:  C Manichanh; L Rigottier-Gois; E Bonnaud; K Gloux; E Pelletier; L Frangeul; R Nalin; C Jarrin; P Chardon; P Marteau; J Roca; J Dore
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

3.  Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.

Authors:  T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

Review 4.  Mucin function in inflammatory bowel disease: an update.

Authors:  Doron Boltin; Tsachi T Perets; Alex Vilkin; Yaron Niv
Journal:  J Clin Gastroenterol       Date:  2013-02       Impact factor: 3.062

5.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

Review 6.  Interactions between the host innate immune system and microbes in inflammatory bowel disease.

Authors:  Clara Abraham; Ruslan Medzhitov
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

7.  Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.

Authors:  Richard Hansen; Richard K Russell; Caroline Reiff; Petra Louis; Freda McIntosh; Susan H Berry; Indrani Mukhopadhya; W Michael Bisset; Andy R Barclay; Jon Bishop; Diana M Flynn; Paraic McGrogan; Sabarinathan Loganathan; Gamal Mahdi; Harry J Flint; Emad M El-Omar; Georgina L Hold
Journal:  Am J Gastroenterol       Date:  2012-10-09       Impact factor: 10.864

8.  Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration.

Authors:  Alemu Fite; Sandra Macfarlane; Elizabeth Furrie; Bahram Bahrami; John H Cummings; Douglas T Steinke; George T Macfarlane
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

Review 9.  Interactions between the microbiota and the immune system.

Authors:  Lora V Hooper; Dan R Littman; Andrew J Macpherson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

10.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms.

Authors:  J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; James Huntley; Noah Fierer; Sarah M Owens; Jason Betley; Louise Fraser; Markus Bauer; Niall Gormley; Jack A Gilbert; Geoff Smith; Rob Knight
Journal:  ISME J       Date:  2012-03-08       Impact factor: 10.302

View more
  31 in total

Review 1.  Microbiome in chronic obstructive pulmonary disease.

Authors:  Eduard Monsó
Journal:  Ann Transl Med       Date:  2017-06

2.  Inferred metagenomic comparison of mucosal and fecal microbiota from individuals undergoing routine screening colonoscopy reveals similar differences observed during active inflammation.

Authors:  Mei San Tang; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Michael Davenport; Soo Ching Lee; Yvonne Al Lim; Kek Heng Chua; P'ng Loke; Ilseung Cho
Journal:  Gut Microbes       Date:  2015-01-20

3.  Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.

Authors:  Ji Li; Aito Ueno; Marietta Iacucci; Miriam Fort Gasia; Humberto B Jijon; Remo Panaccione; Gilaad G Kaplan; Paul L Beck; Joanne Luider; Herman W Barkema; Jiaming Qian; Xianyong Gui; Subrata Ghosh
Journal:  Dig Dis Sci       Date:  2017-06-01       Impact factor: 3.199

4.  Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis.

Authors:  Angélica Cruz-Lebrón; Leticia D'argenio Garcia; Aarthi Talla; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Rafick-Pierre Sékaly; Karina Inacio Ladislau de Carvalho; Alan D Levine
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

5.  Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis.

Authors:  Rajesh Shah; Julia L Cope; Dorottya Nagy-Szakal; Scot Dowd; James Versalovic; Emily B Hollister; Richard Kellermayer
Journal:  Gut Microbes       Date:  2016-05-23

Review 6.  Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.

Authors:  Laila Aldars-García; María Chaparro; Javier P Gisbert
Journal:  Microorganisms       Date:  2021-04-30

7.  Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria.

Authors:  Weiwei Wang; Juan Jovel; Brendan Halloran; Eytan Wine; Jordan Patterson; Glenn Ford; Sandra OʼKeefe; Bo Meng; Deyong Song; Yong Zhang; Zhijian Tian; Shawn T Wasilenko; Mandana Rahbari; Salman Reza; Troy Mitchell; Tracy Jordan; Eric Carpenter; Karen Madsen; Richard Fedorak; Levinus A Dielemann; Gane Ka-Shu Wong; Andrew L Mason
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

Review 8.  Microbiome associations of therapeutic enteral nutrition.

Authors:  Rajesh Shah; Richard Kellermayer
Journal:  Nutrients       Date:  2014-11-21       Impact factor: 5.717

9.  PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.

Authors:  Rosellina Margherita Mancina; Rocco Spagnuolo; Marta Milano; Simona Brogneri; Attilio Morrone; Cristina Cosco; Veronica Lazzaro; Cristina Russo; Yvelise Ferro; Piero Pingitore; Arturo Pujia; Tiziana Montalcini; Patrizia Doldo; Pietro Garieri; Luca Piodi; Flavio Caprioli; Luca Valenti; Stefano Romeo
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

10.  Fish Sidestream-Derived Protein Hydrolysates Suppress DSS-Induced Colitis by Modulating Intestinal Inflammation in Mice.

Authors:  Maria G Daskalaki; Konstantinos Axarlis; Tone Aspevik; Michail Orfanakis; Ourania Kolliniati; Ioanna Lapi; Maria Tzardi; Eirini Dermitzaki; Maria Venihaki; Katerina Kousoulaki; Christos Tsatsanis
Journal:  Mar Drugs       Date:  2021-05-28       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.